CRL Charles River Laboratories International, Inc. Common Stock
$288,77
Harga · Agu 18, 2026
Fundamental per Agu 5, 2026
Rentang 52M
$144–$289
100% of range
Peringkat Analis
BUY
22 analysts
Target Harga
$281
P/E (TTM)
-99.2
ROE
-4.4%
Margin Laba Bersih
-3.6%
Tentang Charles River Laboratories International, Inc. Common Stock Tinjauan perusahaan dari Wikipedia
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation (CRO) headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Baca selengkapnya
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation (CRO) headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration (FDA). The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs.
As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL.
History
Charles River was founded in 1947 by Henry Foster, a young veterinarian who purchased one thousand rat cages from a Virginia farm and set up a one-person laboratory in Boston overlooking the Charles River. He supplied local researchers with laboratory animals.
In 1955, the company's headquarters were relocated to their current home in Wilmington, Massachusetts. The organization became an international entity in 1966 by opening a new animal production facility in France.
The first commercial, comprehensive genetic monitoring program was implemented by Charles River in 1981. Three years later, they were acquired by Bausch & Lomb. In 1988, the organization began creating transgenic mice and rats. In the 1990s, they began in vitro endotoxin testing. In the 1990s, Jim Foster bought Charles River back from Bausch & Lomb, and the company later went public on the New York Stock Exchange.
Charles River launched the Humane Care Imperative in 2002, designed to raise awareness and train employees on animal welfare's importance. The same year, they were named "Company of the Year" by The Boston Globe. The company introduced preconditioning services in 2005 to provide customers with study-ready animals.
In 2008, Charles River signed a ten-year contract to partner with the National Cancer Institute and opened a facility in Frederick, Maryland.
In April 2019, Charles River announced it would cease its San Diego operations, moving the breeding of rodents for testing compounds to Hollister, California.
In March 2023, the Born Free USA animal welfare organization protested against Charles River's plan to export 1,000 endangered juvenile long-tail macaques to Cambodia for testing.
Acquisitions
In 1988, Charles River purchased Specific Pathogen Antigen Free Avian Services (SPAFAS) and serologic diagnostic services Merck, Sharp, and Dohme.
Between 1996 and 2000, the company acquired Endosafe, Inc. and Sierra Biomedical.
In October 2003, Charles River Laboratories merged with Inveresk, a research company based in the United Kingdom. The company was known then as Charles River Laboratories. Inveresk specialised in clinical research and pre-clinical testing, and their main facilities are in Edinburgh, Scotland. In late 2009, Charles River sold its Clinical Services Division in Edinburgh to Quotient Bioresearch.
In 2010, Charles River Laboratories attempted to acquire WuXi PharmaTech, a China-based contract research organization, but the offer was withdrawn when the deal faced opposition from several large Charles River investors, including Relational Investors, JANA Partners, and Neuberger Berman. The proxy advisory firm RiskMetrics had also recommended that Charles River's shareholders vote against the proposed deal.
From 2008 to 2013, Charles River acquires several companies including NewLab Bioquality AG, MIR Preclinical Services, Piedmont Research Center, LLC, Cerebricon, Ltd., Accugenix, and Vital River, allowing the company to expand their research models and services portfolio to drug development and discovery markets in China.
The acquisitions of Argenta and BioFocus in 2014 allowed Charles River to establish itself as a full-service, early-stage contract research organization with integrated in vitro and in vivo capabilities from target discovery through pre-clinical development.
In July 2015, the company announced it would acquire Celsis International for $212 million.
In 2016, the company announced it was set to acquire WIL Research for approximately $585 million in cash and Blue Stream Laboratories.
In August 2017, the business announced it would acquire Brains On-Line.
In January 2018, the company announced it would acquire KWS BioTest for up to £18 million ($24.4 million). In February of the same year, Charles River announced it would acquire MPI Research for approximately $800 million in cash. The transaction was completed on April 3, 2018.
In February 2019, the company announced it would acquire Citoxlab for €448 million in cash (approximately $500 million), including the former acquisitions of the French company, AccelLAB, Atlanbio and Solvo Biotechnology. The transaction was completed on April 29. In December of the same year the business announced it would acquire HemaCare for approximately $380 million in cash.
In August 2020, the company announced it would acquire Cellero for $38 million in cash.
In January 2021, the company announced it would acquire Distributed Bio, Inc., an antibody discovery business.
In February 2021, Charles River announced it would acquire Cognate BioServices, Inc. for $875 million.
In March 2021, Charles River announced the acquisition of Retrogenix for $48 million.
In May 2021, Charles River announced the acquisition of Vigene Biosciences, a gene therapy contract development and manufacturing organization (CDMO), for $292.5 million.
In October 2021, a Japanese subsidiary of Charles River was acquired by Jackson Laboratory for $63M USD.
In April 2022, the company announced it would acquire Explora BioLabs.
In January 2023, the business announced it would acquire SAMDI Tech, Inc.
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
CRL Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$288.77
Kapitalisasi Pasar
$14.21B
P/E (TTM)
-99.2
EPS (TTM)
$-2.91
Pendapatan (TTM)
$4.02B
Imbal Hasil Dividen
—
ROE
-4.4%
D/E Utang/Ekuitas
0.0
Rentang 52M
$144 – $289
CRL Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
$4.02B
2016-12-31
→
2025-12-27
EPS
$-2.91
2016-12-31
→
2025-12-27
Arus Kas Bebas
$518M
2016-12-31
→
2025-12-27
Margin
-3.6%
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
CRL
Median Rekan
P/E (TTM)
-99.2
39.9
P/S (TTM)
3.5
5.6
P/B
4.5
4.1
EV / EBITDA
32.7
—
Price / FCF (Harga / FCF)
27.4
—
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
CRL
Median Rekan
Operating Margin (Margin Operasi)
0.63%
—
Net Profit Margin (Margin Laba Bersih)
-3.6%
11.7%
ROA
-2.0%
4.7%
ROE
-4.4%
8.5%
ROIC
1.1%
—
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
CRL
Median Rekan
Debt / Equity (Utang / Ekuitas)
0.0
15.3
Current Ratio (Rasio Lancar)
1.3
1.7
Quick Ratio (Rasio Cepat)
0.8
—
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
CRL
Median Rekan
Revenue YoY (Pendapatan YoY)
-0.85%
—
Revenue CAGR 3Y (CAGR Pendapatan 3T)
0.33%
—
Revenue CAGR 5Y (CAGR Pendapatan 5T)
6.6%
—
EPS YoY
-97.8%
—
Net Income YoY (Laba Bersih YoY)
-95.3%
—
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
CRL
Median Rekan
CRL Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
22 analis
- Beli Kuat 5 22,7%
- Beli 10 45,5%
- Tahan 7 31,8%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
14 analis · 2026-08-14
Median
$300.00
Rata-rata
$281.00
Sekarang
$288.77
Rendah
$145.00
Tinggi
$318.00
Target median
$300.00
+3,9%
Target rata-rata
$281.00
-2,7%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
0.21%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $3.02 | $2.76 | 0.26% |
| 31 Maret 2026 | $2.06 | $1.96 | 0.10% |
| 31 Des. 2025 | $2.39 | $2.37 | 0.02% |
| 30 Sep. 2025 | $2.43 | $2.36 | 0.07% |
| 30 Juni 2025 | $3.12 | $2.52 | 0.60% |
| 31 Maret 2025 | $2.34 | $2.10 | 0.24% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | — |
| ILMN | $20.65B | 24.8 | -0.66% | 19.6% | 34.1% | 66.1% |
| MTD | $28.38B | 33.2 | 4.0% | 21.6% | -615.5% | 59.4% |
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | — |
| TEM | — | -41.9 | 83.4% | -19.3% | -61.2% | — |
| RVTY | $10.86B | 46.7 | 3.7% | 8.5% | 3.3% | — |
| TECH | $7.97B | 111.8 | 5.2% | 6.0% | 3.7% | 64.8% |
| BIO | — | — | — | — | — | — |
| RGEN | $9.23B | 190.5 | 16.4% | 6.6% | 2.4% | — |
| TEM | — | -41.9 | 83.4% | -19.3% | -61.2% | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 15
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.02B | $4.05B | $4.13B | $3.98B | $3.54B | $2.92B | $2.62B | $2.27B | $1.86B | $1.68B | $1.36B | $1.30B | |
| Cost of Revenue | · | · | · | · | · | · | · | · | $290M | $277M | $264M | $266M | |
| SG&A Expense | $743M | $751M | $748M | $665M | $620M | $529M | $518M | $444M | $371M | $365M | $300M | $269M | |
| Operating Income | $25M | $227M | $617M | $651M | $590M | $433M | $351M | $331M | $288M | $238M | $206M | $178M | |
| Interest Expense | · | · | $137M | $59M | $74M | $86M | $61M | $64M | $30M | $28M | $15M | $12M | |
| Interest Income | $5M | $9M | $5M | $780.0K | $652.0K | $834.0K | $2M | $812.0K | $690.0K | $1M | $1M | $1M | |
| Other Non-op | $-23M | $-17M | $96M | $31M | $-36M | $100M | $12M | $13M | $38M | $12M | $3M | $11M | |
| Pretax Income | $-100M | $93M | $581M | $623M | $481M | $447M | $304M | $282M | $297M | $223M | $195M | $178M | |
| Income Tax | $43M | $68M | $101M | $130M | $82M | $82M | $50M | $54M | $171M | $67M | $43M | $48M | |
| Net Income | $-144M | $22M | $475M | $486M | $391M | $364M | $252M | $226M | $123M | $155M | $149M | $127M | |
| EPS (Basic) | $-2.91 | $0.20 | $9.27 | $9.57 | $7.77 | $7.35 | $5.17 | $4.72 | $2.60 | $3.29 | $3.21 | $2.72 | |
| EPS (Diluted) | $-2.91 | $0.20 | $9.22 | $9.48 | $7.60 | $7.20 | $5.07 | $4.62 | $2.54 | $3.23 | $3.13 | $2.66 | |
| Shares (Basic) | 49,564,000 | 51,380,000 | 51,227,000 | 50,812,000 | 50,293,000 | 49,550,000 | 48,730,000 | 47,947,000 | 47,481,000 | 47,014,000 | 46,496,000 | 46,627,000 | |
| Shares (Diluted) | 49,564,000 | 51,628,000 | 51,451,000 | 51,301,000 | 51,425,000 | 50,611,000 | 49,693,000 | 49,018,000 | 48,564,000 | 47,958,000 | 47,634,000 | 47,558,000 | |
| EBITDA | $428M | $589M | $931M | $955M | $855M | $668M | $549M | $493M | $419M | $364M | $301M | $274M |
Neraca 30
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $214M | $195M | $277M | $234M | $241M | $228M | $238M | $195M | $164M | $118M | $118M | $160M | |
| Short-term Investments | · | · | · | · | $1M | $1M | $941.0K | $885.0K | $28M | $4M | $21M | · | |
| Receivables | $709M | $721M | $780M | $752M | $643M | $618M | $514M | $472M | $430M | $364M | $270M | $258M | |
| Inventory | $299M | $279M | $380M | $256M | $199M | $186M | $161M | $128M | $115M | $96M | $94M | $89M | |
| Prepaid Expense | $129M | $106M | $83M | $108M | $97M | $73M | $56M | $49M | $81M | $45M | $47M | $45M | |
| Other Current Assets | · | · | · | · | · | $0 | $300.0K | $300.0K | $0 | $45M | $47M | $73M | |
| Current Assets | $1.45B | $1.40B | $1.61B | $1.44B | $1.27B | $1.20B | $1.02B | $898M | $827M | $657M | $559M | $579M | |
| PP&E (Net) | $1.66B | $1.60B | $1.64B | $1.47B | $1.29B | $1.12B | $1.04B | $933M | $782M | $756M | $678M | $677M | |
| PP&E (Gross) | $3.19B | $3.06B | $2.98B | $2.63B | $2.39B | $2.21B | $2.02B | $1.81B | $1.58B | $1.46B | $1.32B | $1.33B | |
| Accum. Depreciation | $1.54B | $1.45B | $1.34B | $1.16B | $1.10B | $1.09B | $978M | $874M | $801M | $706M | $645M | $655M | |
| Goodwill | $2.76B | $2.85B | $3.10B | $2.85B | $2.71B | $1.81B | $1.54B | $1.25B | $805M | $788M | $439M | $321M | |
| Intangibles | $340M | $723M | $864M | $955M | $1.06B | $788M | $689M | $611M | $370M | $394M | $281M | $281M | |
| Other Non-current Assets | $293M | $278M | $309M | $148M | $152M | $353M | $213M | $144M | $124M | $88M | $72M | $73M | |
| Total Assets | $7.14B | $7.53B | $8.20B | $7.60B | $7.02B | $5.49B | $4.69B | $3.86B | $2.93B | $2.71B | $2.07B | $1.87B | |
| Accounts Payable | $149M | $140M | $169M | $206M | $198M | $122M | $111M | $66M | $78M | $68M | $37M | $34M | |
| Accrued Liabilities | $270M | $232M | $228M | $220M | $229M | $150M | $139M | $107M | $90M | $84M | $89M | $67M | |
| Current Liabilities | $1.12B | $994M | $1.06B | $1.09B | $1.03B | $840M | $710M | $558M | $464M | $430M | $312M | $295M | |
| Capital Leases | $434M | $484M | $419M | $390M | $253M | $156M | $116M | · | · | · | · | · | |
| Deferred Tax | $95M | $107M | $191M | $216M | $240M | $217M | $167M | $144M | $90M | $56M | $48M | $23M | |
| Other Non-current Liabilities | $138M | $195M | $223M | $175M | $243M | $205M | $183M | $179M | $195M | $159M | $89M | $100M | |
| Total Liabilities | $3.92B | $4.02B | $4.54B | $4.58B | $4.43B | $3.35B | $3.03B | $2.52B | $1.87B | $1.86B | $1.30B | $1.17B | |
| Long-term Debt | · | · | · | · | · | · | · | $1.61B | $1.09B | $1.18B | $814M | $717M | |
| Total Debt | $166.0K | $155.0K | $3M | $1M | $101.0K | $47M | $36M | $1.65B | $1.12B | $1.21B | $836M | $754M | |
| Common Stock | $492.0K | $511.0K | $513.0K | $509.0K | $505.0K | $498.0K | $489.0K | $482.0K | $875.0K | $863.0K | $855.0K | $845.0K | |
| Retained Earnings | $1.39B | $1.81B | $1.89B | $1.43B | $981M | $625M | $280M | $42M | $289M | $165M | $11M | $-139M | |
| Treasury Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $55.0K | $1.66B | $1.55B | $1.54B | $1.42B | |
| AOCI | $-172M | $-317M | $-196M | $-262M | $-165M | $-139M | $-178M | $-173M | $-145M | $-254M | $-136M | $-74M | |
| Stockholders' Equity | $3.16B | $3.46B | $3.60B | $2.98B | $2.53B | $2.11B | $1.63B | $1.32B | $1.05B | $837M | $733M | $672M | |
| Liabilities + Equity | $7.14B | $7.53B | $8.20B | $7.60B | $7.02B | $5.49B | $4.69B | $3.86B | $2.93B | $2.71B | $2.07B | $1.87B | |
| Shares Outstanding | 49,217,000 | 51,141,000 | 51,338,000 | 50,944,000 | 50,480,000 | 49,767,000 | 48,936,000 | 48,209,000 | 47,402,000 | 47,363,000 | 46,698,000 | 47,327,000 |
Arus Kas 18
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $403M | $362M | $314M | $304M | $266M | $235M | $198M | $162M | $131M | $127M | $95M | $96M | |
| Stock-based Comp | $71M | $70M | $72M | $74M | $71M | $56M | $57M | $47M | $44M | $44M | $40M | $31M | |
| Deferred Tax | $-75M | $-67M | $-51M | $-33M | $-20M | $2M | $-21M | $-10M | $28M | $3M | $4M | $9M | |
| Amort. of Intangibles | $179M | $138M | $137M | $147M | $125M | $112M | $90M | $65M | $41M | $42M | $24M | $26M | |
| Restructuring | $100M | $107M | $30M | $8M | $7M | $13M | $14M | $10M | $5M | $18M | $8M | $8M | |
| Other Non-cash | $483M | $348M | $-126M | $-211M | $53M | $-111M | $-5M | $16M | $-8M | $-28M | $-395.0K | · | |
| Operating Cash Flow | $738M | $735M | $684M | $620M | $761M | $547M | $481M | $441M | $318M | $317M | $307M | $252M | |
| CapEx | $219M | $233M | $319M | $325M | $229M | $167M | $141M | $140M | $82M | $55M | $63M | $57M | |
| Investing Cash Flow | $-209M | $-245M | $-563M | $-608M | $-1.44B | $-602M | $-682M | $-955M | $-73M | $-693M | · | · | |
| Debt Issued | $1.23B | $1.08B | $776M | $2.95B | $6.95B | $2.23B | $3.36B | $2.76B | $237M | $1.04B | · | · | |
| Net Debt Issued | $1.23B | $1.08B | $776M | $2.95B | $6.95B | $2.23B | $3.36B | $2.76B | · | · | · | · | |
| Stock Repurchased | $361M | $119M | $24M | $39M | $41M | $24M | $18M | $14M | $107M | $12M | $117M | $122M | |
| Net Stock Activity | $-361M | $-119M | $-24M | $-39M | $-41M | $-24M | $-18M | $-14M | $-107M | $-12M | $-117M | $-122M | |
| Financing Cash Flow | $-537M | $-551M | $-86M | $-42M | $673M | $47M | $232M | $558M | $-208M | $381M | · | · | |
| Net Change in Cash | $10M | $-79M | $43M | $-5M | $13M | $-7M | $43M | $31M | $46M | $-69.0K | $-43M | $4M | |
| Taxes Paid | $120M | $126M | $90M | $76M | $75M | $60M | $54M | $68M | · | · | · | · | |
| Free Cash Flow | $518M | $502M | $365M | $295M | $532M | $380M | $340M | $301M | $236M | $245M | $225M | $195M | |
| Levered FCF | · | · | $252M | $248M | $471M | $309M | $290M | $250M | $223M | $226M | $213M | $186M |
Profitabilitas 7
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 0.63% | 5.6% | 14.9% | 16.4% | 16.7% | 14.8% | 13.4% | 14.6% | 15.5% | 14.1% | 15.1% | 13.7% | |
| Net Margin | -3.6% | 0.55% | 11.5% | 12.2% | 11.0% | 12.5% | 9.6% | 10.0% | 6.6% | 9.2% | 10.9% | · | |
| Pretax Margin | -2.5% | 2.3% | 14.1% | 15.7% | 13.6% | 15.3% | 11.6% | 12.4% | 16.0% | 13.3% | 14.3% | 13.7% | |
| EBITDA Margin | 10.7% | 14.5% | 22.6% | 24.0% | 24.2% | 22.8% | 20.9% | 21.8% | 22.5% | 21.6% | 22.1% | 21.1% | |
| ROA | -2.0% | 0.28% | 6.0% | 6.7% | 6.2% | 7.1% | 5.9% | 6.7% | 4.4% | 6.5% | 7.6% | · | |
| ROE | -4.4% | 0.63% | 14.4% | 17.6% | 16.8% | 19.4% | 17.1% | 19.2% | 13.1% | 19.7% | 21.2% | · | |
| ROIC | 1.1% | 1.8% | 14.2% | 17.3% | 19.3% | 16.4% | 17.6% | 9.0% | 5.6% | 8.1% | 10.2% | 9.1% |
Likuiditas & Solvabilitas 5
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.4 | 1.5 | 1.3 | 1.2 | 1.4 | 1.4 | 1.6 | 1.8 | 1.5 | 1.8 | 2.0 | |
| Quick Ratio | 0.8 | 0.9 | 1.0 | 0.9 | 0.9 | 1.0 | 1.1 | 1.2 | 1.3 | 1.1 | 1.2 | 1.4 | |
| Debt / Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.3 | 1.1 | 1.4 | 1.1 | 1.1 | |
| LT Debt / Equity | · | · | · | · | · | · | · | 1.2 | 1.0 | 1.4 | 1.1 | 1.1 | |
| Interest Coverage | · | · | 4.5 | 11.0 | 8.0 | 5.0 | 5.8 | 5.2 | 9.7 | 8.6 | 13.7 | 14.9 |
Efisiensi 3
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | 2.7 | 2.9 | 2.9 | 3.0 | |
| Receivables Turnover | 5.6 | 5.4 | 5.4 | 5.7 | 5.6 | 5.2 | 5.3 | 5.0 | 4.7 | 5.3 | 5.2 | 5.4 |
Tingkat Pertumbuhan 7
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -0.85% | -1.9% | 3.9% | 12.3% | 21.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 0.33% | 4.6% | 12.2% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | -97.8% | -2.7% | 24.7% | 5.6% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | -70.3% | 8.6% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | -95.3% | -2.4% | 24.4% | 7.3% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | -61.6% | 9.2% | · | · | · | · | · | · | · | · | · |
Valuasi (TTM) 14
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.02B | $4.05B | $4.13B | $3.98B | $3.54B | $2.92B | $2.62B | $2.27B | $1.86B | $1.68B | $1.36B | $1.30B | |
| Net Income TTM | $-144M | $22M | $475M | $486M | $391M | $364M | $252M | $226M | $123M | $155M | $149M | $127M | |
| Market Cap | $10.02B | $9.52B | $12.14B | $11.10B | $18.64B | $12.53B | $7.43B | $5.39B | $5.19B | $3.61B | $3.74B | $3.04B | |
| Enterprise Value | $9.81B | $9.33B | $11.86B | $10.87B | $18.40B | $12.34B | $7.23B | $6.84B | $6.12B | $4.70B | $4.46B | $3.64B | |
| P/E | -70.0 | 930.8 | 25.6 | 23.0 | 48.6 | 35.0 | 30.0 | 24.2 | 43.1 | 23.6 | 25.6 | 24.2 | |
| P/S | 2.5 | 2.4 | 2.9 | 2.8 | 5.3 | 4.3 | 2.8 | 2.4 | 2.8 | 2.1 | 2.7 | 2.3 | |
| P/B | 3.2 | 2.8 | 3.4 | 3.7 | 7.4 | 5.9 | 4.5 | 4.1 | 5.0 | 4.3 | 5.1 | 4.5 | |
| P / Tangible Book | 166.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 13.6 | 13.0 | 17.7 | 17.9 | 24.5 | 22.9 | 15.5 | 12.2 | 16.3 | 12.0 | 13.0 | 12.1 | |
| P / FCF | 19.3 | 19.0 | 33.2 | 37.6 | 35.0 | 33.0 | 21.8 | 17.9 | 22.0 | 14.7 | 16.6 | 15.6 | |
| EV / EBITDA | 22.9 | 15.8 | 12.7 | 11.4 | 21.5 | 18.5 | 13.2 | 13.9 | 14.6 | 12.9 | 14.8 | 13.3 | |
| EV / FCF | 18.9 | 18.6 | 32.5 | 36.9 | 34.6 | 32.5 | 21.2 | 22.7 | 26.0 | 19.2 | 19.8 | 18.6 | |
| EV / Revenue | 2.4 | 2.3 | 2.9 | 2.7 | 5.2 | 4.2 | 2.8 | 3.0 | 3.3 | 2.8 | 3.3 | 2.8 | |
| Earnings Yield | -1.4% | 0.11% | 3.9% | 4.3% | 2.1% | 2.9% | 3.3% | 4.1% | 2.3% | 4.2% | 3.9% | 4.1% |
Laporan Laba Rugi 14
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.00B | $996M | $994M | $1.00B | $1.03B | $984M | $1.00B | $1.01B | $1.03B | $1.01B | $1.01B | $1.03B | $1.03B | $1.10B | $989M | |
| Cost of Revenue | · | · | · | · | · | · | · | $661M | $672M | $667M | · | $665M | $652M | · | · | |
| SG&A Expense | $229M | $159M | $196M | $178M | $192M | $178M | $196M | $199M | $170M | $186M | $197M | $176M | $175M | $200M | $184M | |
| Operating Income | $120M | $120M | $-283M | $134M | $100M | $75M | $-168M | $117M | $152M | $126M | $133M | $152M | $168M | $164M | $151M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $35M | · | $34M | $34M | · | $11M | |
| Interest Income | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $3M | $2M | $2M | $1M | $806.0K | $343.0K | $122.0K | |
| Other Non-op | $-37M | $-124M | $12M | $-23M | $154.0K | $-12M | $-23M | $3M | $-2M | $6M | $108M | $-6M | $-3M | $116M | $-17M | |
| Income Tax | $54M | $-15M | $-18M | $32M | $19M | $10M | $-3M | $21M | $25M | $25M | $20M | $25M | $27M | $56M | $25M | |
| Net Income | $-1M | $-15M | $-277M | $54M | $52M | $25M | $-214M | $70M | $94M | $73M | $187M | $87M | $103M | $187M | $96M | |
| EPS (Basic) | $-0.03 | $-0.30 | $-5.58 | $1.11 | $1.06 | $0.50 | $-4.20 | $1.34 | $1.75 | $1.31 | $3.65 | $1.70 | $2.02 | $3.68 | $1.90 | |
| EPS (Diluted) | $-0.03 | $-0.30 | $-5.57 | $1.10 | $1.06 | $0.50 | $-4.17 | $1.33 | $1.74 | $1.30 | $3.64 | $1.69 | $2.01 | $3.66 | $1.88 | |
| Shares (Basic) | 48,021,000 | 48,951,000 | -99,475,000 | 49,213,000 | 49,149,000 | 50,677,000 | -103,002,000 | 51,394,000 | 51,551,000 | 51,437,000 | 28,000 | 51,283,000 | 51,097,000 | -101,521,000 | 50,870,000 | |
| Shares (Diluted) | 48,021,000 | 48,951,000 | -100,031,000 | 49,426,000 | 49,316,000 | 50,853,000 | -103,643,000 | 51,583,000 | 51,846,000 | 51,842,000 | -42,000 | 51,607,000 | 51,428,000 | -102,590,000 | 51,283,000 | |
| EBITDA | $187M | $187M | · | $219M | $220M | $195M | · | $206M | $238M | $211M | · | $230M | $245M | · | $226M |
Neraca 28
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $192M | $192M | $214M | $207M | $183M | $229M | $195M | $210M | $179M | $327M | · | $157M | $202M | · | $194M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $950.0K | |
| Receivables | $712M | $700M | $709M | $734M | $768M | $757M | $721M | $754M | $762M | $787M | · | $799M | $788M | · | $771M | |
| Inventory | $346M | $360M | $299M | $303M | $280M | $290M | $279M | $336M | $349M | $361M | · | $293M | $263M | · | $262M | |
| Prepaid Expense | $179M | $135M | $129M | $166M | $130M | $100M | $106M | $102M | $111M | $99M | · | $93M | $92M | · | $97M | |
| Current Assets | $1.53B | $1.49B | $1.45B | $1.53B | $1.47B | $1.51B | $1.40B | $1.49B | $1.50B | $1.67B | · | $1.44B | $1.45B | · | $1.42B | |
| PP&E (Net) | $1.49B | $1.51B | $1.66B | $1.59B | $1.61B | $1.59B | $1.60B | · | · | · | · | · | · | · | · | |
| PP&E (Gross) | $2.96B | $2.94B | $3.19B | $3.09B | $3.10B | $3.05B | $3.06B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $1.46B | $1.43B | $1.54B | $1.50B | $1.50B | $1.46B | $1.45B | · | · | · | · | · | · | · | · | |
| Goodwill | $3.08B | $3.04B | $2.76B | $2.92B | $2.94B | $2.87B | $2.85B | $3.12B | $3.08B | $3.07B | · | $2.88B | $2.90B | · | $2.78B | |
| Intangibles | $253M | $249M | $340M | $571M | $602M | $656M | $723M | $778M | $800M | $828M | · | $886M | $958M | · | $968M | |
| Other Non-current Assets | $588M | $826M | $293M | $291M | $296M | $294M | $278M | $307M | $301M | $303M | · | $155M | $154M | · | $430M | |
| Total Assets | $7.53B | $7.73B | $7.14B | $7.51B | $7.56B | $7.58B | $7.53B | $8.00B | $7.95B | $8.15B | · | $7.61B | $7.70B | · | $7.38B | |
| Accounts Payable | $141M | $134M | $149M | $170M | $146M | $149M | $140M | $136M | $133M | $130M | · | $136M | $120M | · | $182M | |
| Accrued Liabilities | $380M | $372M | $270M | $229M | $232M | $242M | $232M | $208M | $192M | $191M | · | $198M | $221M | · | $197M | |
| Current Liabilities | $1.13B | $1.09B | $1.12B | $1.12B | $1.08B | $1.05B | $994M | $1.01B | $948M | $955M | · | $994M | $981M | · | $1.01B | |
| Capital Leases | $408M | $393M | $434M | $443M | $454M | $475M | $484M | $433M | $429M | $418M | · | $390M | $418M | · | $369M | |
| Deferred Tax | $79M | $81M | $95M | $123M | $109M | $107M | $107M | $168M | $165M | $180M | · | $185M | $212M | · | $196M | |
| Other Non-current Liabilities | $403M | $511M | $138M | $189M | $185M | $196M | $195M | $237M | $225M | $235M | · | $173M | $187M | · | $195M | |
| Total Liabilities | $4.64B | $4.74B | $3.92B | $4.06B | $4.16B | $4.34B | $4.02B | $4.18B | $4.18B | $4.45B | · | $4.26B | $4.54B | · | $4.71B | |
| Total Debt | $5M | $7M | · | $54.0K | $98.0K | $121.0K | · | $157.0K | $435.0K | $459.0K | · | $797.0K | · | · | $0 | |
| Common Stock | $496.0K | $493.0K | $492.0K | $514.0K | $513.0K | $512.0K | $511.0K | $517.0K | $517.0K | $515.0K | · | $514.0K | $512.0K | · | $510.0K | |
| Retained Earnings | $1.37B | $1.37B | $1.39B | $1.94B | $1.89B | $1.84B | $1.81B | $2.12B | $2.05B | $1.96B | · | $1.72B | $1.54B | · | $1.28B | |
| Treasury Stock | $323M | $210M | $0 | $363M | $363M | $357M | $0 | $120M | $18M | $9M | · | $24M | $19M | · | $38M | |
| AOCI | $-196M | $-191M | $-172M | $-192M | $-166M | $-265M | $-317M | $-193M | $-270M | $-250M | · | $-268M | $-239M | · | $-396M | |
| Stockholders' Equity | $2.84B | $2.94B | $3.16B | $3.41B | $3.35B | $3.19B | $3.46B | $3.78B | $3.72B | $3.64B | · | $3.31B | $3.11B | · | $2.63B | |
| Liabilities + Equity | $7.53B | $7.73B | $7.14B | $7.51B | $7.56B | $7.58B | $7.53B | $8.00B | $7.95B | $8.15B | · | $7.61B | $7.70B | · | $7.38B | |
| Shares Outstanding | 47,728,000 | 48,167,000 | 49,217,000 | 49,215,000 | 49,209,000 | 49,115,000 | 51,141,000 | 51,134,000 | 51,613,000 | 51,510,000 | · | 51,296,000 | 51,182,000 | 50,944,000 | 50,877,000 |
Arus Kas 16
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $67M | $67M | $78M | $85M | $120M | $120M | $102M | $88M | $86M | $85M | $81M | $79M | $77M | $78M | $75M | |
| Stock-based Comp | $20M | $22M | $18M | $23M | $17M | $13M | $17M | $19M | $17M | $17M | $20M | $23M | $13M | $22M | $22M | |
| Amort. of Intangibles | $15M | $15M | $21M | $27M | $65M | $65M | $41M | $32M | $32M | $33M | $34M | $34M | $35M | $35M | $36M | |
| Restructuring | $23M | $32M | $26M | $17M | $32M | $24M | $41M | $31M | $18M | $17M | $8M | $15M | $3M | $4M | $1M | |
| Other Non-cash | · | $-34M | · | · | · | $13M | · | · | · | $-45M | · | · | $-84M | · | · | |
| Operating Cash Flow | $180M | $41M | $148M | $214M | $205M | $172M | $159M | $252M | $194M | $130M | $221M | $205M | $109M | $235M | $133M | |
| CapEx | $31M | $56M | $89M | $36M | $35M | $59M | $76M | $39M | $39M | $79M | $78M | $66M | $107M | $89M | $72M | |
| Investing Cash Flow | $28M | $-408M | $-93M | $-34M | $-37M | $-45M | $-76M | $-21M | $-62M | $-86M | $-238M | $-80M | $-169M | $44M | $-92M | |
| Debt Issued | $353M | $912M | $157M | $107M | $547M | $416M | $105M | $236M | $440M | $301M | $443M | $51M | $192M | $154M | $618M | |
| Net Debt Issued | · | $912M | · | · | · | $416M | · | · | · | $301M | · | · | $192M | · | · | |
| Stock Repurchased | $116M | $208M | $96.0K | $93.0K | $7M | $353M | $124.0K | $101M | $9M | $9M | $139.0K | $38.0K | $19M | $159.0K | $24.0K | |
| Net Stock Activity | · | $-208M | · | · | · | $-353M | · | · | · | $-9M | · | · | $-19M | · | · | |
| Financing Cash Flow | $-165M | $348M | $-52M | $-153M | $-227M | $-105M | $-76M | $-208M | $-286M | $18M | $124M | $-163M | $25M | $-249M | $-52M | |
| Net Change in Cash | $42M | $-18M | $7M | $24M | $-47M | $26M | $-6M | $31M | $-158M | $54M | $119M | $-43M | $-32M | $45M | $-11M | |
| Taxes Paid | $16M | $2M | $27M | $19M | $57M | $17M | $31M | $23M | $53M | $19M | $15M | $14M | $14M | · | · | |
| Free Cash Flow | · | $-15M | · | · | · | $112M | · | · | · | $51M | · | · | $3M | · | · |
Profitabilitas 5
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.9% | 12.0% | · | 13.3% | 9.7% | 7.6% | · | 11.6% | 14.8% | 12.4% | · | 14.8% | 16.3% | · | 15.3% | |
| Net Margin | -0.15% | -1.5% | · | 5.4% | 5.1% | 2.6% | · | 6.9% | 9.2% | 7.2% | · | 8.5% | 10.0% | · | 9.8% | |
| EBITDA Margin | 18.6% | 18.8% | · | 21.8% | 21.3% | 19.8% | · | 20.4% | 23.2% | 20.9% | · | 22.4% | 23.8% | · | 22.8% | |
| ROA | -0.02% | -0.19% | · | 0.70% | 0.67% | 0.32% | · | 0.89% | 1.2% | 0.92% | · | 1.2% | · | · | 1.3% | |
| ROE | -0.05% | -0.48% | · | 1.5% | 1.5% | 0.75% | · | 2.0% | 2.7% | 2.2% | · | 2.9% | · | · | 3.8% |
Likuiditas & Solvabilitas 4
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.5 | 1.6 | 1.7 | · | 1.5 | · | · | 1.4 | |
| Quick Ratio | 0.8 | 0.8 | · | 0.8 | 0.9 | 0.9 | · | 1.0 | 1.0 | 1.2 | · | 1.0 | · | · | 1.0 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 3.6 | · | 4.5 | 4.9 | · | 13.3 |
Efisiensi 3
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | · | · | 0.1 | |
| Inventory Turnover | · | · | · | · | · | · | · | 2.1 | 2.1 | 2.1 | · | · | · | · | · | |
| Receivables Turnover | 1.4 | 1.4 | · | 1.4 | 1.3 | 1.3 | · | 1.3 | 1.3 | 1.3 | · | 1.3 | · | · | 1.4 |
Valuasi (TTM) 13
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.04B | $4.02B | · | $4.03B | $4.05B | $4.03B | · | $4.07B | $4.12B | $4.13B | · | $4.11B | $3.91B | · | $3.77B | |
| Net Income TTM | $90M | $117M | · | $202M | $242M | $262M | · | $324M | $351M | $360M | · | $384M | $402M | · | $402M | |
| Market Cap | $10.30B | $7.67B | · | $7.31B | $7.38B | $7.64B | · | $10.14B | $10.66B | $13.96B | · | $10.05B | · | · | $9.54B | |
| Enterprise Value | $10.11B | $7.48B | · | $7.10B | $7.20B | $7.41B | · | $9.93B | $10.48B | $13.63B | · | $9.90B | · | · | $9.35B | |
| P/E | 117.9 | 67.4 | · | 37.2 | 32.4 | 31.9 | · | 32.7 | 31.2 | 39.3 | · | 26.2 | 25.8 | · | 23.9 | |
| P/S | 2.6 | 1.9 | · | 1.8 | 1.8 | 1.9 | · | 2.5 | 2.6 | 3.4 | · | 2.4 | · | · | 2.5 | |
| P/B | 3.6 | 2.6 | · | 2.1 | 2.2 | 2.4 | · | 2.7 | 2.9 | 3.8 | · | 3.0 | · | · | 3.6 | |
| P / Cash Flow | · | 186.6 | · | · | · | 44.5 | · | · | · | 107.5 | · | · | · | · | · | |
| P / FCF | · | -516.9 | · | · | · | 68.0 | · | · | · | 275.0 | · | · | · | · | · | |
| EV / EBITDA | 54.0 | 40.0 | · | 32.4 | 32.8 | 38.0 | · | 48.3 | 44.1 | 64.5 | · | 43.0 | · | · | 41.4 | |
| EV / FCF | · | -504.4 | · | · | · | 65.9 | · | · | · | 268.6 | · | · | · | · | · | |
| EV / Revenue | 2.5 | 1.9 | · | 1.8 | 1.8 | 1.8 | · | 2.4 | 2.5 | 3.3 | · | 2.4 | · | · | 2.5 | |
| Earnings Yield | 0.85% | 1.5% | · | 2.7% | 3.1% | 3.1% | · | 3.1% | 3.2% | 2.5% | · | 3.8% | 3.9% | · | 4.2% |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 | |
|---|---|---|---|---|---|
| Pendapatan | $4.02B | $4.05B | $4.13B | $3.98B | $3.54B |
| Margin Operasi % | 0.63% | 5.6% | 14.9% | 16.4% | 16.7% |
| Laba Bersih | $-144M | $22M | $475M | $486M | $391M |
| EPS Dilusian | $-2.91 | $0.20 | $9.22 | $9.48 | $7.60 |
Neraca
| 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 | |
|---|---|---|---|---|---|
| Utang / Ekuitas | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Rasio Lancar | 1.3 | 1.4 | 1.5 | 1.3 | 1.2 |
| Rasio Cepat | 0.8 | 0.9 | 1.0 | 0.9 | 0.9 |
Arus Kas
| 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 | |
|---|---|---|---|---|---|
| Arus Kas Bebas | $518M | $502M | $365M | $295M | $532M |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 616 pengaju · $7.8B total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 82 (-1 vs Kuartal sebelumnya) | 59 (-23 vs Kuartal sebelumnya) | 180 (-11 vs Kuartal sebelumnya) | 201 (+15 vs Kuartal sebelumnya) | +5.0M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| FMR LLC | $737.350.307 | 3.251.247 | 9,42% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $714.227.026 | 3.149.288 | 9,12% | Saham |
| HARRIS ASSOCIATES L P | $508.269.048 | 2.241.144 | 6,49% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $501.427.927 | 2.210.979 | 6,40% | Saham |
| STATE STREET CORP | $422.800.968 | 1.864.284 | 5,40% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $348.883.077 | 1.538.354 | 4,46% | Saham |
| CITADEL ADVISORS LLC | $270.696.771 | 1.193.601 | 3,46% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $259.130.041 | 1.144.937 | 3,31% | Saham |
| EARNEST PARTNERS LLC | $254.007.295 | 1.120.011 | 3,24% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $223.361.616 | 984.883 | 2,85% | Saham |
| AMERIPRISE FINANCIAL INC | $192.886.814 | 850.503 | 2,46% | Saham |
| NEUBERGER BERMAN GROUP LLC | $192.182.793 | 847.488 | 2,45% | Saham |
| Clearbridge Investments, LLC | $177.185.527 | 781.276 | 2,26% | Saham |
| COOKE & BIELER LP | $171.369.328 | 755.630 | 2,19% | Saham |
| VICTORY CAPITAL MANAGEMENT INC | $150.762.735 | 664.768 | 1,93% | Saham |
| MILLENNIUM MANAGEMENT LLC | $110.324.717 | 486.462 | 1,41% | Saham |
| BANK OF AMERICA CORP /DE/ | $104.921.899 | 462.639 | 1,34% | Saham |
| Gotham Asset Management, LLC | $98.233.181 | 433.146 | 1,25% | Saham |
| Amundi | $93.528.650 | 412.402 | 1,19% | Saham |
| NORGES BANK | $83.921.372 | 370.040 | 1,07% | Saham |
| MARSHALL WACE, LLP | $76.947.125 | 339.288 | 0,98% | Saham |
| Iron Triangle Partners LP | $75.748.141 | 379.728 | 0,97% | Saham |
| ALLIANCEBERNSTEIN L.P. | $64.615.913 | 374.585 | 0,83% | Saham |
| SNYDER CAPITAL MANAGEMENT L P | $63.899.443 | 281.756 | 0,82% | Saham |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $63.174.169 | 278.558 | 0,81% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $63.095.473 | 278.211 | 0,81% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $61.384.115 | 270.665 | 0,78% | Saham |
| PRIMECAP MANAGEMENT CO/CA/ | $60.523.448 | 266.870 | 0,77% | Saham |
| GOLDMAN SACHS GROUP INC | $57.319.812 | 252.744 | 0,73% | Saham |
| Meridiem Capital Partners LP | $56.012.367 | 246.979 | 0,72% | Saham |
| Alyeska Investment Group, L.P. | $53.295.650 | 235.000 | 0,68% | Saham |
| Quantinno Capital Management LP | $49.020.824 | 216.150 | 0,63% | Saham |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $48.415.129 | 213.480 | 0,62% | Saham |
| Boston Trust Walden Corp | $46.506.918 | 205.066 | 0,59% | Saham |
| Burgundy Asset Management Ltd. | $45.453.909 | 278.329 | 0,58% | Saham |
| SRS Investment Management, LLC | $42.496.817 | 187.384 | 0,54% | Saham |
| LOOMIS SAYLES & CO L P | $38.517.487 | 169.838 | 0,49% | Saham |
| JONES FINANCIAL COMPANIES LLLP | $37.184.513 | 172.350 | 0,47% | Saham |
| PERCEPTIVE ADVISORS LLC | $31.750.600 | 140.000 | 0,41% | Saham |
| LAKEWOOD CAPITAL MANAGEMENT, LP | $30.389.860 | 134.000 | 0,39% | Saham |
| NEW YORK STATE COMMON RETIREMENT FUND | $29.879.583 | 131.750 | 0,38% | Saham |
| BlackRock, Inc. | $29.025.945 | 127.986 | 0,37% | Saham |
| PICTON MAHONEY ASSET MANAGEMENT | $26.340.305 | 116.144 | 0,34% | Saham |
| FIL Ltd | $25.184.576 | 111.048 | 0,32% | Saham |
| Candriam S.C.A. | $23.824.478 | 105.152 | 0,30% | Saham |
| Clark Capital Management Group, Inc. | $23.010.567 | 101.462 | 0,29% | Saham |
| Vanguard Global Advisers, LLC | $22.453.344 | 99.005 | 0,29% | Saham |
| Swiss National Bank | $22.452.210 | 99.000 | 0,29% | Saham |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | $20.491.384 | 90.354 | 0,26% | Saham |
| ENVESTNET ASSET MANAGEMENT INC | $20.280.546 | 89.424 | 0,26% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $19.730.730 | 87.000 | 0,25% | Opsi beli |
| NOMURA HOLDINGS INC | $19.672.672 | 86.744 | 0,25% | Saham |
| RHUMBLINE ADVISERS | $19.484.825 | 85.916 | 0,25% | Saham |
| Ilex Capital Partners (UK) LLP | $18.413.760 | 81.193 | 0,24% | Saham |
| Aristotle Capital Boston, LLC | $18.273.438 | 80.574 | 0,23% | Saham |
| CITADEL ADVISORS LLC | $17.485.509 | 77.100 | 0,22% | Opsi beli |
| NICHOLAS COMPANY, INC. | $16.305.067 | 71.895 | 0,21% | Saham |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $15.172.024 | 66.899 | 0,19% | Saham |
| Mitsubishi UFJ Asset Management Co., Ltd. | $15.164.087 | 66.864 | 0,19% | Saham |
| Ranger Investment Management, L.P. | $15.009.416 | 66.182 | 0,19% | Saham |
| California Public Employees Retirement System | $14.670.818 | 64.689 | 0,19% | Saham |
| Assenagon Asset Management S.A. | $14.020.385 | 61.821 | 0,18% | Saham |
| ASSETMARK, INC | $13.939.194 | 61.463 | 0,18% | Saham |
| Rhenman & Partners Asset Management AB | $12.972.388 | 57.200 | 0,17% | Saham |
| RIVERBRIDGE PARTNERS LLC | $12.859.587 | 56.703 | 0,16% | Saham |
| TD Asset Management Inc | $12.854.230 | 56.679 | 0,16% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $12.836.314 | 56.600 | 0,16% | Opsi jual |
| Laurus Investment Counsel Inc. | $12.365.663 | 71.685 | 0,16% | Saham |
| KING LUTHER CAPITAL MANAGEMENT CORP | $12.204.023 | 53.812 | 0,16% | Saham |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $11.552.133 | 50.938 | 0,15% | Saham |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $10.732.081 | 47.278 | 0,14% | Saham |
| RAYMOND JAMES FINANCIAL INC | $10.506.727 | 46.328 | 0,13% | Saham |
| VANGUARD ASSET MANAGEMENT, Ltd | $10.472.482 | 46.177 | 0,13% | Saham |
| KENNEDY CAPITAL MANAGEMENT LLC | $9.914.950 | 43.719 | 0,13% | Saham |
| BARCLAYS PLC | $9.909.816 | 43.696 | 0,13% | Saham |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $9.827.670 | 56.972 | 0,13% | Saham |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $9.382.529 | 41.371 | 0,12% | Saham |
| Park West Asset Management LLC | $9.343.748 | 41.200 | 0,12% | Saham |
| State of Tennessee, Department of Treasury | $8.457.000 | 37.290 | 0,11% | Saham |
| J.P. Marvel Investment Advisors, LLC | $8.456.092 | 37.286 | 0,11% | Saham |
| CASTLEARK MANAGEMENT LLC | $8.174.646 | 36.045 | 0,10% | Saham |
| JANE STREET GROUP, LLC | $7.869.613 | 34.700 | 0,10% | Opsi beli |
| Pine Ridge Advisers LLC | $7.710.860 | 34.000 | 0,10% | Saham |
| PRUDENTIAL FINANCIAL INC | $7.346.635 | 32.394 | 0,09% | Saham |
| Capricorn Fund Managers Ltd | $7.092.630 | 31.274 | 0,09% | Saham |
| STATE OF WISCONSIN INVESTMENT BOARD | $7.000.554 | 30.868 | 0,09% | Saham |
| FIRST TRUST ADVISORS LP | $6.951.290 | 30.651 | 0,09% | Saham |
| Caption Management, LLC | $6.803.700 | 30.000 | 0,09% | Opsi jual |
| Engineers Gate Manager LP | $6.637.463 | 29.267 | 0,08% | Saham |
| LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE | $6.351.027 | 28.004 | 0,08% | Saham |
| Midwest Trust Co | $6.091.126 | 26.858 | 0,08% | Saham |
| VAN ECK ASSOCIATES CORP | $5.942.578 | 26.203 | 0,08% | Saham |
| SEI INVESTMENTS CO | $5.929.630 | 26.150 | 0,08% | Saham |
| Sendero Wealth Management, LLC | $5.909.468 | 26.057 | 0,08% | Saham |
| 13D Management LLC | $5.851.182 | 25.800 | 0,07% | Saham |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $5.500.853 | 31.889 | 0,07% | Saham |
| D. E. Shaw & Co., Inc. | $5.462.691 | 24.087 | 0,07% | Saham |
| INVESTMENT HOUSE LLC | $5.447.042 | 24.018 | 0,07% | Saham |
| LPL Financial LLC | $5.409.169 | 23.851 | 0,07% | Saham |
| LRT Capital Management, LLC | $5.348.842 | 23.585 | 0,07% | Saham |
Orang dalam perusahaan 57 orang dalam · 21 pejabat · 27 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Glenn Coleman | EVP & Chief Financial Officer | 29 Mei 2026 A | 27.752 | 0 | 0 | $0 |
| Flavia Pease | Corporate Executive VP & CFO | 31 Mei 2025 F | 17.297 | 0 | 0 | $0 |
| David Ross Smith | Corporate Executive VP & CFO | 3 Maret 2022 M | 25.819 | 0 | 0 | $0 |
| Davide Molho | President & COO | 24 Juli 2018 M | 17.155 | 0 | 0 | $0 |
| Mark Mintz | EVP, Chief Information Officer | 31 Mei 2026 F | 9.546 | 0 | 0 | $0 |
| William D Barbo | Corporate Executive VP & CCO | 7 Nov. 2024 G | 23.337 | 0 | 0 | $0 |
| John W Kuo | CEVP General Counsel & CCO | 1 Juni 2020 A | 3.171 | 0 | 0 | $0 |
| David P Johst | Corporate Executive VP | 29 Mei 2020 A | 224.478 | 0 | 0 | $0 |
| John J Crowley | SVP, Chief Accounting Officer | 1 Okt. 2016 F | 5.599 | 0 | 0 | $0 |
| Nancy Gillett | Corporate Executive VP | 2 Maret 2016 S | 11.034 | 0 | 0 | $0 |
| Jorg Geller | Corporate Executive VP | 25 Feb. 2015 M | 14.094 | 0 | 0 | $0 |
| RENAUD REAL H | Corp. Executive VP | 11 Agu 2010 F | 74.390 | 0 | 0 | $0 |
| Christopher Berthoux | Executive Vice President | 26 Feb. 2010 A | 31.897 | 0 | 0 | $0 |
| Joanne P Acford | Corp. Sr VP, GC and Corp. Sec | 11 Agu 2007 F | 37.109 | 0 | 0 | $0 |
| David J Elliott | Officer | 29 Juni 2007 M | 11.750 | 0 | 0 | $0 |
| Cheri L Walker | Corporate Senior VP | 1 Mei 2007 A | 6.262 | 0 | 0 | $0 |
| Stephanie B Wells | Senior Vice President | 2 April 2007 A | 11.500 | 0 | 0 | $0 |
| Nicholas Ventresca | Senior Vice President | 2 April 2007 F | 12.713 | 0 | 0 | $0 |
| John C Ho | Senior Vice President | 23 Feb. 2007 A | 12.710 | 0 | 0 | $0 |
| Brian Bathgate | Corporate Vice President | 27 Feb. 2006 S | 16.134 | 0 | 0 | $0 |
| Alastair Stuart Mcewan | Corporate VP | 23 Des. 2004 M | 8.000 | 0 | 0 | $0 |
| Steven Barg | Direktur | 2 Juni 2026 A | 3.287 | 0 | 0 | $0 |
| Nancy C Andrews | Direktur | 12 Mei 2026 G | 3.964 | 0 | 0 | $0 |
| Reshema Kemps-Polanco | Direktur | 8 Mei 2026 A | 4.563 | 0 | 0 | $0 |
| George Llado | Direktur | 8 Mei 2026 A | 6.702 | 0 | 0 | $0 |
| Abraham Ceesay | Direktur | 8 Mei 2026 A | 2.384 | 0 | 0 | $0 |
| Mark J Enyedy | Direktur | 8 Mei 2026 A | 2.384 | 0 | 0 | $0 |
| Paul W Graves | Direktur | 8 Mei 2026 A | 2.384 | 0 | 0 | $0 |
| Craig B. Thompson | Direktur | 8 Mei 2026 A | 3.851 | 0 | 0 | $0 |
| Martin Mackay | Direktur | 8 Mei 2026 A | 17.137 | 0 | 0 | $0 |
| Virginia M Wilson | Direktur | 8 Mei 2026 A | 6.349 | 0 | 0 | $0 |
| George Massaro | Direktur | 15 Mei 2025 S | 5.575 | 0 | 0 | $0 |
| Richard F Wallman | Direktur | 7 Nov. 2024 S | 0 | 0 | 0 | $0 |
| Deborah Turner Kochevar | Direktur | 13 Mei 2024 A | 7.894 | 0 | 0 | $0 |
| Robert J Bertolini | Direktur | 13 Mei 2024 A | 32.802 | 0 | 0 | $0 |
| Richard C Reese | Direktur | 15 Mei 2023 A | 65.541 | 0 | 0 | $0 |
| George M Milne JR | Direktur | 7 Mei 2021 A | 29.079 | 0 | 0 | $0 |
| Stephen D Chubb | Direktur | 23 Feb. 2021 M | 40.529 | 0 | 0 | $0 |
| Jean-Paul Mangeolle | Direktur | 22 Mei 2019 A | 3.886 | 0 | 0 | $0 |
| William Waltrip | Direktur | 5 Des. 2012 S | 21.830 | 0 | 0 | $0 |
| Samuel O Thier MD | Direktur | 9 Mei 2012 A | 18.230 | 0 | 0 | $0 |
| Douglas E Rogers | Direktur | 7 Mei 2010 A | 12.859 | 0 | 0 | $0 |
| Nancy T Chang | Direktur | 7 Mei 2010 A | 31.010 | 0 | 0 | $0 |
| Linda Mcgoldrick | Direktur | 13 Feb. 2006 A | — | 0 | 0 | $0 |
| Walter S Nimmo | Direktur | 25 Feb. 2005 S | 149.447 | 0 | 0 | $0 |
| John Urquhart | Direktur | 17 Feb. 2005 A | 11.738 | 0 | 0 | $0 |
| Louise S Mccrary | Direktur | 17 Feb. 2005 A | — | 0 | 0 | $0 |
| Robert Cawthorn | Direktur | 2 Juni 2004 G | 278.600 | 0 | 0 | $0 |
| Shannon M Parisotto | — | 11 Agu 2026 M | 4.807 | 0 | 2 | $-2.365.755 |
| Birgit Girshick | — | 11 Agu 2026 M | 36.013 | 0 | 1 | $-1.819.350 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 6 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| JANA PARTNERS LLC ×4 pengajuan | 4 Agu 2011 | — | Pengajuan awal | — | SEC |
| Relational Investors, LLC, Relational Investors Mid-Cap Fund I, L.P., Relational Investors Mid-Cap Fund II, L.P., Ralph V. Whitworth, David H. Batchelder, California State Teachers’ Retirement System ×3 pengajuan | 9 Feb. 2011 | — | Pengajuan awal | — | SEC |
| Neuberger Berman Group LLC, Neuberger Berman LLC, Neuberger Berman Management ×3 pengajuan | 7 Des. 2010 | — | Pengajuan awal | — | SEC |
| Orang pelapor yang tidak diungkapkan | 16 Juni 2010 | — | Pengajuan awal | — | SEC |
| Orang pelapor yang tidak diungkapkan | 7 Juni 2010 | — | Pengajuan awal | Investasi pasif | SEC |
| Charles River Laboratories International, Inc. IRS No. 061397316 | 5 Mei 2010 | — | Pengajuan awal | Kampanye dewan | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 135 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| RSPH · Invesco Exchange-Traded Fund Trust | 2,18% | 63.652 SH | 8 Agu 2026 | Harian |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,49% | 4.749 NS | 30 April 2026 | N-PORT |
| EPSB · Harbor ETF Trust | 1,33% | 370 NS | 30 April 2026 | N-PORT |
| SPHB · Invesco Exchange-Traded Fund Trust … | 1,18% | 41.597 SH | 8 Agu 2026 | Harian |
| EPMV · Harbor ETF Trust | 1,09% | 291 NS | 30 April 2026 | N-PORT |
| IBB · iShares Trust | 0,97% | 349.491 SH | 8 Agu 2026 | Harian |
| EPSV · Harbor ETF Trust | 0,90% | 270 NS | 30 April 2026 | N-PORT |
| TAX · EA Series Trust | 0,80% | 1.131 NS | 29 Mei 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0,66% | 612 NS | 30 April 2026 | N-PORT |
| HIBL · Direxion Shares ETF Trust | 0,50% | 2.356 NS | 30 April 2026 | N-PORT |
| ISCV · iShares Trust | 0,40% | 10.497 SH | 8 Agu 2026 | Harian |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,38% | 11.925 NS | 30 April 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,38% | 25.401 SH | 8 Agu 2026 | Harian |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | 0,36% | 1.145.000 PA | 8 Agu 2026 | Harian |
| IQSM · New York Life Investments ETF Trust | 0,33% | 6.161 NS | 30 April 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0,29% | 22.440 NS | 30 April 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,27% | 996.151 SH | 8 Agu 2026 | Harian |
| DFAT · Dimensional ETF Trust | 0,26% | 212.321 NS | 30 April 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,23% | 701.498 SH | 8 Agu 2026 | Harian |
| ESML · iShares Trust | 0,23% | 24.979 SH | 8 Agu 2026 | Harian |
| BKMC · BNY Mellon ETF Trust | 0,22% | 8.115 NS | 30 April 2026 | N-PORT |
| IYH · iShares Trust | 0,21% | 29.370 SH | 8 Agu 2026 | Harian |
| ISCB · iShares Trust | 0,20% | 2.125 SH | 8 Agu 2026 | Harian |
| SMMD · iShares Trust | 0,17% | 24.455 SH | 8 Agu 2026 | Harian |
| FSMD · FIDELITY COVINGTON TRUST | 0,17% | 24.528 NS | 30 April 2026 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0,17% | 133.341 NS | 31 Mei 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,16% | 138.243 NS | 30 April 2026 | N-PORT |
| IXJ · iShares Trust | 0,16% | 25.598 SH | 8 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,16% | 148.331 SH | 8 Agu 2026 | Harian |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,15% | 18.369 NS | 30 April 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,15% | 6.079 NS | 31 Mei 2026 | N-PORT |
| WSML · iShares Trust | 0,13% | 6.018 SH | 8 Agu 2026 | Harian |
| FHLC · FIDELITY COVINGTON TRUST | 0,13% | 22.674 NS | 30 April 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,13% | 59.338 NS | 30 April 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,13% | 1.102.914 SH | 8 Agu 2026 | Harian |
| VGMS · VANGUARD MALVERN FUNDS | 0,13% | 315.000 PA | 8 Agu 2026 | Harian |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,13% | 4.072 SH | 8 Agu 2026 | Harian |
| RXL · ProShares Trust | 0,13% | 513 NS | 31 Mei 2026 | N-PORT |
| IWS · iShares Trust | 0,13% | 74.284 SH | 8 Agu 2026 | Harian |
| REVS · Columbia ETF Trust I | 0,12% | 2.082 NS | 30 April 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0,12% | 982 NS | 30 April 2026 | N-PORT |
| SMLF · iShares Trust | 0,12% | 18.532 SH | 8 Agu 2026 | Harian |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,11% | 3.280 NS | 30 April 2026 | N-PORT |
| FBCV · FIDELITY COVINGTON TRUST | 0,11% | 1.032 NS | 30 April 2026 | N-PORT |
| IWR · iShares Trust | 0,09% | 199.595 SH | 8 Agu 2026 | Harian |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,09% | 1.986 NS | 31 Mei 2026 | N-PORT |
| IEUS · iShares Trust | 0,09% | 4.951 SH | 8 Agu 2026 | Harian |
| XOEF · iShares Trust | 0,07% | 61 SH | 8 Agu 2026 | Harian |
| VSDB · VANGUARD MALVERN FUNDS | 0,07% | 635.000 PA | 8 Agu 2026 | Harian |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,07% | 5.261 NS | 30 April 2026 | N-PORT |